Distinctive CD8+ T cell activation by antigen-presenting plasmacytoid dendritic cells compared to conventional dendritic cells
Open Access
- 11 March 2025
- journal article
- Published by Elsevier in Cell Reports
- Vol. 44 (3) , 115413
Abstract
No abstract availableKeywords
Funding Information
- Danmarks Frie Forskningsfond (8020-00210B)
- Lundbeck Foundation (R238-2016-2708)
- Danmarks Frie Forskningsfond (2034-00057B)
- Aarhus Universitets Forskningsfond
- Horizon 2020
- HORIZON EUROPE European Research Council (754513)
- H2020 Marie Skłodowska-Curie Actions
- Aarhus Universitet
This publication has 106 references indexed in Scilit:
- Expression and potential role of CCL4 in CD8+T cells in NSCLCClinical and Translational Oncology, 2022
- Plasmacytoid dendritic cells during COVID-19: Ally or adversary?Cell Reports, 2022
- Patients’ NK cell stimulation with activated plasmacytoid dendritic cells increases dinutuximab-induced neuroblastoma killingCancer Immunology, Immunotherapy, 2020
- CCL3 Signaling in the Tumor Microenvironment2020
- Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell PopulationCell Reports, 2019
- In vitro differentiated plasmacytoid dendritic cells as a tool to induce anti-leukemia activity of natural killer cellsCancer Immunology, Immunotherapy, 2017
- pDCs efficiently process synthetic long peptides to induce functional virus‐ and tumour‐specific T‐cell responsesEuropean Journal of Immunology, 2014
- Targeting antigen to bone marrow stromal cell‐2 expressed by conventional and plasmacytoid dendritic cells elicits efficient antigen presentationEuropean Journal of Immunology, 2013
- Vaccination with plasmacytoid dendritic cells induces protection against infection with Leishmania major in miceEuropean Journal of Immunology, 2007
- Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cellsEuropean Journal of Immunology, 2001